Skip to main content

Table 6 The joined analysis of the Beijing and Guangzhou population

From: Lack of association between polymorphisms of MASP2and susceptibility to SARS coronavirus infection

  SARS cases controls    
Genotype P1 P2 C1 C2 P1 vs.P2 C1vs.C2 P1, P2 vs. C1, C2
  (n = 272) (n = 104) (n = 232) (n = 291) P P P
rs2261695        
AA 189 (70.3%) 73
(75.3%)
174 (75.0%) 193
(70.4%)
0.35 0.25 0.76
AG 77
(28.6%)
22
(22.7%)
56
(24.1%)
78
(28.5%)
   
GG 3
(1.1%)
2
(2.0%)
2
(0.9%)
3
(1.1%)
   
rs2273346        
TT 186 (68.4%) 64
(61.5%)
147
(63.4%)
190
(66.2%)
0.21 0.50 0.63
TC 78 (28.7%) 36
(34.6%)
71
(30.6%)
82
(28.6%)
   
CC 8
(2.9%)
4
(3.8%)
14
(6%)
15
(5.2%)
   
rs12711521        
TT 105
(38.5%)
58
(55.8%)
106
(45.7%)
139
(47.8%)
0.003 0.64 0.30
TG 137
(50.5%)
36
(34.6%)
95
(40.9%)
108
(37.1%)
   
GG 30
(11.0%)
10
(9.6%)
31
(13.4%)
44
(15.1%)
   
rs7548659        
TT 173
(69.5%)
70
(67.3%)
157
(67.7%)
205
(70.5%)
0.69 0.50 0.91
TG 61 (24.5%) 25
(24.0%)
67
(28.9%)
75
(27.8%)
   
GG 15
(6.0%)
9
(8.7%)
8
(3.4%)
11
(1.7%)
   
Diplotypea        
TT 344
(63.2%)
128
(61.5%)
304
(65.5%)
380
(65.3%)
0.89 1.00 0.31
TG 108
(19.9%)
42
(20.2%)
60
(12.9%)
76
(13.0%)
   
CT 6
(1.1%)
4
(1.9%)
2
(0.5%)
4
(0.7%)
   
CG 86
(15.8%)
34
(16.4%)
98
(21.1%)
122
(21.0%)
   
  1. P1:SARS patients from Beijing; P2: SARS patients from Guangzhou; C1:controls from Beijing; C2:controls from Guangzhou.